Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells
Flaria El Khoury, Laurent Corcos, Stéphanie Durand, et al.
International Journal of Oncology (2016) Vol. 49, Iss. 6, pp. 2558-2568
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors
Sabrina Dallavalle, Vladimir Dobričić, Loretta Lazzarato, et al.
Drug Resistance Updates (2020) Vol. 50, pp. 100682-100682
Open Access | Times Cited: 241
Cancer stem cells in colorectal cancer: Signaling pathways involved in stemness and therapy resistance
Nasim Ebrahimi, Maral Afshinpour, Siavash Seifollahy Fakhr, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 182, pp. 103920-103920
Open Access | Times Cited: 62
CD26/DPP4 - a potential biomarker and target for cancer therapy
Njanja Enz, Gwendolyn Vliegen, Ingrid De Meester, et al.
Pharmacology & Therapeutics (2019) Vol. 198, pp. 135-159
Open Access | Times Cited: 140
Redox-Mediated Mechanism of Chemoresistance in Cancer Cells
Eun-Kyung Kim, Mingyeong Jang, Min-Jeong Song, et al.
Antioxidants (2019) Vol. 8, Iss. 10, pp. 471-471
Open Access | Times Cited: 131
The Phenolic compound Kaempferol overcomes 5-fluorouracil resistance in human resistant LS174 colon cancer cells
Ichrak Riahi-Chebbi, Soumaya Souid, Houcemeddine Othman, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 117
Targeting cancer stem cells in squamous cell carcinoma
Demeng Chen, Cun‐Yu Wang
Precision Clinical Medicine (2019) Vol. 2, Iss. 3, pp. 152-165
Open Access | Times Cited: 79
The pathological role of C-X-C chemokine receptor type 4 (CXCR4) in colorectal cancer (CRC) progression; special focus on molecular mechanisms and possible therapeutics
Ahmed Hjazi, F. Nasir, Rabia Noor, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154616-154616
Closed Access | Times Cited: 17
MiR-148a and miR-152 reduce tamoxifen resistance in ER+ breast cancer via downregulating ALCAM
Ming-Jenn Chen, Ya-Min Cheng, Chien‐Chung Chen, et al.
Biochemical and Biophysical Research Communications (2017) Vol. 483, Iss. 2, pp. 840-846
Closed Access | Times Cited: 51
Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1
Andrew Fesler, Hua Liu, Jingfang Ju
Oncotarget (2017) Vol. 9, Iss. 2, pp. 2367-2383
Open Access | Times Cited: 51
Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer
Zeting Yuan, Xin Liang, Yueping Zhan, et al.
British Journal of Cancer (2020) Vol. 122, Iss. 9, pp. 1342-1353
Open Access | Times Cited: 50
Revolutionizing the landscape of colorectal cancer treatment: The potential role of immune checkpoint inhibitors
Mai F. Tolba
International Journal of Cancer (2020) Vol. 147, Iss. 11, pp. 2996-3006
Open Access | Times Cited: 49
Novel N-Substituted Amino Acid Hydrazone-Isatin Derivatives: Synthesis, Antioxidant Activity, and Anticancer Activity in 2D and 3D Models In Vitro
Ingrida Tumosienė, Ilona Jonuškienė, Kristina Kantminienė, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7799-7799
Open Access | Times Cited: 38
Optimization of Clove Oil Nanoemulsions: Evaluation of Antioxidant, Antimicrobial, and Anticancer Properties
José Nabor Haro-González, Brenda Nathalie Schlienger de Alba, Moisés Martínez‐Velázquez, et al.
Colloids and Interfaces (2023) Vol. 7, Iss. 4, pp. 64-64
Open Access | Times Cited: 14
Inhibition ofHAX-1by miR-125a reverses cisplatin resistance in laryngeal cancer stem cells
Jiajia Liu, Qinglai Tang, Shisheng Li, et al.
Oncotarget (2016) Vol. 7, Iss. 52, pp. 86446-86456
Open Access | Times Cited: 44
Cytotoxic effects of the newly-developed chemotherapeutic agents 17-AAG in combination with oxaliplatin and capecitabine in colorectal cancer cell lines
Mahshid Mohammadian, Shima Zeynali, Anahita Fathi Azarbayjani, et al.
Research in Pharmaceutical Sciences (2017) Vol. 12, Iss. 6, pp. 517-517
Open Access | Times Cited: 41
Inhibition of PGE2/EP4 receptor signaling enhances oxaliplatin efficacy in resistant colon cancer cells through modulation of oxidative stress
Huakang Huang, Oladimeji Aladelokun, Takayasu Ideta, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 37
DNAJB8 in small extracellular vesicles promotes Oxaliplatin resistance through TP53/MDR1 pathway in colon cancer
Zheng Wang, Yi Li, Rui Mao, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 17
The TH1902 Docetaxel Peptide-Drug Conjugate Inhibits Xenografts Growth of Human SORT1-Positive Ovarian and Triple-Negative Breast Cancer Stem-like Cells
Michel Demeule, Cyndia Charfi, Jean-Christophe Currie, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1910-1910
Open Access | Times Cited: 17
ARID3A inhibits colorectal cancer cell stemness and drug-resistance by targeting a multitude of stemness-associated genes
Tamal Kanti Gope, Debankur Pal, Amit Srivastava, et al.
Life Sciences (2025) Vol. 372, pp. 123642-123642
Closed Access
Molecular and phenotypic characterization of 5-FU resistant colorectal cancer cells: toward enrichment of cancer stem cells
Amirhesam Babajnai, Saeed Rahmani, Milad Asadi, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Role of transmembrane glycoprotein mucin 1 (MUC1) in various types of colorectal cancer and therapies: Current research status and updates
Mei Guo, Chengzhong You, Jun Dou
Biomedicine & Pharmacotherapy (2018) Vol. 107, pp. 1318-1325
Closed Access | Times Cited: 31
Overcoming acquired resistance of gefitinib in lung cancer cells without T790M by AZD9291 or Twist1 knockdown in vitro and in vivo
Zhongwei Liu, Weimin Gao
Archives of Toxicology (2019) Vol. 93, Iss. 6, pp. 1555-1571
Open Access | Times Cited: 26
Influence of Innate Immunity on Cancer Cell Stemness
Anna Pastò, Francesca Maria Consonni, Antonio Sica
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3352-3352
Open Access | Times Cited: 26
Exploiting fourier transform infrared and Raman microspectroscopies on cancer stem cells from oral squamous cells carcinoma: new evidence of acquired cisplatin chemoresistance
Valentina Notarstefano, Simona Sabbatini, Chiara Pro, et al.
The Analyst (2020) Vol. 145, Iss. 24, pp. 8038-8049
Closed Access | Times Cited: 26
Cell Death, by Any Other Name…
Mustapha Kandouz
Cells (2024) Vol. 13, Iss. 4, pp. 325-325
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top